Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Boato, Francesco ^a,b   Rosenberger, Karen ^c   Nelissen, Sofie ^a   Geboes, Lies ^a   Peters, Eva M ^c,d   Nitsch, Robert ^e   Hendrix, Sven ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b SORBONNE UNIVERSITÉ   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Corticospinal tract; Glial scar; IL 1 ; Spinal cord compression injury

Indexed keywords

INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; PYRAMIDAL TRACT; SCAR FORMATION; SPINAL CORD COMPRESSION; SPINAL CORD LESION; WHITE MATTER;

EID: 84872143205     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-6     Document Type: Article

References (44)

1. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640. 10.1038/nri1664, 16034365.
2. Bauer J, Berkenbosch F, Van Dam AM, Dijkstra CD. Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol 1993, 48:13-21. 10.1016/0165-5728(93)90053-2, 8227304.
3. Desson SE, Ferguson AV. Interleukin 1β modulates rat subfornical organ neurons as a result of activation of a non-selective cationic conductance. J Physiol 2003, 550(Pt 1):113-122. 2343005, 12879863.
4. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
5. Boato F, Hechler D, Rosenberger K, Lüdecke D, Peters EM, Nitsch R, Hendrix S. Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro. J Neuroinflammation 2011, 8:183. 10.1186/1742-2094-8-183, 3275552, 22200088.
6. Edoff K, Jerregard H. Effects of IL-1β, IL-6 or LIF on rat sensory neurons co-cultured with fibroblast-like cells. J Neurosci Res 2002, 67:255-263. 10.1002/jnr.10092, 11782969.
7. Zeise ML, Madamba S, Siggins GR. Interleukin-1 beta increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul Pept 1992, 39:1-7. 10.1016/0167-0115(92)90002-C, 1579655.
8. John GR, Lee SC, Song X, Rivieccio M, Brosnan CF. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 2005, 49:161-176. 10.1002/glia.20109, 15472994.
9. Gölz G, Uhlmann L, Lüdecke D, Markgraf N, Nitsch R, Hendrix S. The cytokine/neurotrophin axis in peripheral axon outgrowth. Eur J Neurosci 2006, 24:2721-2730. 10.1111/j.1460-9568.2006.05155.x, 17156198.
10. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996, 16:932-940.
11. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 2007, 27:4403-4412. 10.1523/JNEUROSCI.5376-06.2007, 17442825.
12. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-680. discussion 681, 10.1161/01.STR.26.4.676, 7709417.
13. Wang CX, Olschowka JA, Wrathall JR. Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 1997, 759:190-196. 10.1016/S0006-8993(97)00254-0, 9221936.
14. Wang XJ, Kong KM, Qi WL, Ye WL, Song PS. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol Sin 2005, 26:934-942. 10.1111/j.1745-7254.2005.00152.x, 16038625.
15. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1β promotes repair of the CNS. J Neurosci 2001, 21:7046-7052.
16. Temporin K, Tanaka H, Kuroda Y, Okada K, Yachi K, Moritomo H, Murase T, Yoshikawa H. IL-1β promotes neurite outgrowth by deactivating RhoA via p38 MAPK pathway. Biochem Biophys Res Commun 2008, 365:375-380. 10.1016/j.bbrc.2007.10.198, 17996195.
17. Temporin K, Tanaka H, Kuroda Y, Okada K, Yachi K, Moritomo H, Murase T, Yoshikawa H. Interleukin-1 beta promotes sensory nerve regeneration after sciatic nerve injury. Neurosci Lett 2008, 440:130-133. 10.1016/j.neulet.2008.05.081, 18556121.
18. Boato F, Hendrix S, Huelsenbeck SC, Hofmann F, Grosse G, Djalali S, Klimaschewski L, Auer M, Just I, Ahnert-Hilger G, Höltje M. C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. J Cell Sci 2010, 123(Pt 10):1652-1662.
19. Sato A, Ohtaki H, Tsumuraya T, Song D, Ohara K, Asano M, Iwakura Y, Atsumi T, Shioda S. Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J Neuroinflammation 2012, 9:65. 10.1186/1742-2094-9-65, 3353190, 22483094.
20. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 1996, 183:1427-1436. 10.1084/jem.183.4.1427, 2192516, 8666901.
21. Loske P, Boato F, Hendrix S, Piepgras J, Just I, Ahnert-Hilger G, Höltje M. Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode. J Neurochem 2012, 120:1084-1096.
22. Hechler D, Boato F, Nitsch R, Hendrix S. Differential regulation of axon outgrowth and reinnervation by neurotrophin-3 and neurotrophin-4 in the hippocampal formation. Exp Brain Res 2010, 205:215-221. 10.1007/s00221-010-2355-7, 20640412.
23. Höltje M, Djalali S, Hofmann F, Münster-Wandowski A, Hendrix S, Boato F, Dreger SC, Grosse G, Henneberger C, Grantyn R, Just I, Ahnert-Hilger G. A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J 2009, 23:1115-1126. 10.1096/fj.08-116855, 19047066.
24. Schmitt KR, Boato F, Diestel A, Hechler D, Kruglov A, Berger F, Hendrix S. Hypothermia-induced neurite outgrowth is mediated by tumor necrosis factor-alpha. Brain Pathol 2010, 20:771-779.
25. Schmitt KR, Kern C, Lange PE, Berger F, Abdul-Khaliq H, Hendrix S. S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth. Neurosci Res 2007, 59:68-73. 10.1016/j.neures.2007.05.011, 17604861.
26. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006, 23(5):635-659. 10.1089/neu.2006.23.635, 16689667.
27. De Ryck M, Van Reempts J, Duytschaever H, Van Deuren B, Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res 1992, 573:44-60. 10.1016/0006-8993(92)90112-M, 1576535.
28. Metz GA, Whishaw IQ. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2002, 115:169-179. 10.1016/S0165-0270(02)00012-2, 11992668.
29. Steward O, Zheng B, Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol 2003, 459:1-8. 10.1002/cne.10593, 12629662.
30. Wang X, Budel S, Baughman K, Gould G, Song KH, Strittmatter SM. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma 2009, 26:81-95. 10.1089/neu.2007.0464, 2913782, 19125588.
31. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007, 500:267-285. 10.1002/cne.21149, 17111361.
32. Nesic O, Xu GY, McAdoo D, High KW, Hulsebosch C, Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 2001, 18:947-956. 10.1089/089771501750451857, 11565605.
33. Liu S, Xu GY, Johnson KM, Echetebu C, Ye ZS, Hulsebosch CE, McAdoo DJ. Regulation of interleukin-1β by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res 2008, 1231:63-74.
34. Perrin FE, Lacroix S, Avilés-Trigueros M, David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration. Brain 2005, 128(Pt 4):854-866.
35. Soiampornkul R, Tong L, Thangnipon W, Balazs R, Cotman CW. Interleukin-1β interferes with signal transduction induced by neurotrophin-3 in cortical neurons. Brain Res 2008, 1188:189-197. 2409119, 18036576.
36. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 2008, 29:1380-1393. 10.1016/j.neurobiolaging.2007.02.027, 17467122.
37. Sung CS, Wong CS. Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1beta. Acta Anaesthesiol Taiwan 2007, 45:103-109.
38. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 2001, 26(24 Suppl):S2-S12.
39. Eyupoglu IY, Savaskan NE, Bräuer AU, Nitsch R, Heimrich B. Identification of neuronal cell death in a model of degeneration in the hippocampus. Brain Res Brain Res Protoc 2003, 11:1-8. 10.1016/S1385-299X(02)00186-1, 12697257.
40. Wolf SA, Fisher J, Bechmann I, Steiner B, Kwidzinski E, Nitsch R. Neuroprotection by T-cells depends on their subtype and activation state. J Neuroimmunol 2002, 133:72-80. 10.1016/S0165-5728(02)00367-3, 12446010.
41. Vidal PM, Lemmens E, Geboes L, Vangansewinkel T, Nelissen S, Hendrix S. Late blocking of peripheral TNF-α is ineffective after spinal cord injury in mice. Immunobiology 2012,
42. Prang P, Del Turco D, Kapfhammer JP. Regeneration of entorhinal fibers in mouse slice cultures is age dependent and can be stimulated by NT-4, GDNF, and modulators of G-proteins and protein kinase C. Exp Neurol 2001, 169:135-147. 10.1006/exnr.2001.7648, 11312566.
43. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988, 8:709-714.
44. Herx LM, Yong VW. Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol 2001, 60:961-971.